Yili Ding

1.2k total citations
62 papers, 983 citations indexed

About

Yili Ding is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Yili Ding has authored 62 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 29 papers in Organic Chemistry and 10 papers in Pharmaceutical Science. Recurrent topics in Yili Ding's work include Carbohydrate Chemistry and Synthesis (26 papers), Glycosylation and Glycoproteins Research (23 papers) and Drug Solubulity and Delivery Systems (10 papers). Yili Ding is often cited by papers focused on Carbohydrate Chemistry and Synthesis (26 papers), Glycosylation and Glycoproteins Research (23 papers) and Drug Solubulity and Delivery Systems (10 papers). Yili Ding collaborates with scholars based in United States, China and Canada. Yili Ding's co-authors include Ole Hindsgaul, Minoru Fukuda, Bingyun Wang, Zhong‐Jian Jia, Steven A. Hofstadler, Richard H. Griffey, Eric E. Swayze, Osamu Kanie, Jiunn‐Chern Yeh and Edgar Ong and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Carbohydrate Polymers.

In The Last Decade

Yili Ding

61 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yili Ding United States 17 674 462 136 79 66 62 983
Stephen A. Margosiak United States 21 925 1.4× 351 0.8× 106 0.8× 133 1.7× 15 0.2× 28 1.6k
Özlem Doǧan Ekici United States 9 829 1.2× 514 1.1× 55 0.4× 76 1.0× 24 0.4× 15 1.5k
Juliana L. Asgian United States 8 685 1.0× 479 1.0× 48 0.4× 77 1.0× 23 0.3× 9 1.2k
Christine Jaxel France 24 1.8k 2.7× 193 0.4× 103 0.8× 50 0.6× 20 0.3× 44 2.0k
Tomowo Kobayashi Japan 19 487 0.7× 186 0.4× 56 0.4× 59 0.7× 31 0.5× 27 1.0k
S.M. Soisson United States 19 1.1k 1.6× 277 0.6× 185 1.4× 62 0.8× 7 0.1× 32 1.6k
Anthony J. Cocuzza United States 13 813 1.2× 359 0.8× 38 0.3× 101 1.3× 30 0.5× 19 1.4k
Gary T. Wang United States 17 775 1.1× 403 0.9× 100 0.7× 208 2.6× 12 0.2× 33 1.3k
Zhimeng Wu China 22 1.1k 1.6× 235 0.5× 57 0.4× 40 0.5× 31 0.5× 101 1.5k
Martin Haraldsson Sweden 15 808 1.2× 428 0.9× 59 0.4× 38 0.5× 7 0.1× 29 1.1k

Countries citing papers authored by Yili Ding

Since Specialization
Citations

This map shows the geographic impact of Yili Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yili Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yili Ding more than expected).

Fields of papers citing papers by Yili Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yili Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yili Ding. The network helps show where Yili Ding may publish in the future.

Co-authorship network of co-authors of Yili Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yili Ding. A scholar is included among the top collaborators of Yili Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yili Ding. Yili Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Charles Z., et al.. (2025). Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin. Frontiers in Veterinary Science. 12. 1611154–1611154.
2.
3.
Ding, Yili, et al.. (2024). Preparation and evaluation of fenbendazole methyl-β-cyclodextrin inclusion complexes. BMC Veterinary Research. 20(1). 214–214. 3 indexed citations
4.
Ding, Yili, et al.. (2023). Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin. Frontiers in Pharmacology. 14. 1138686–1138686. 11 indexed citations
5.
6.
Ding, Yili, et al.. (2023). The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole. Molecules. 28(21). 7295–7295. 8 indexed citations
7.
El‐Ashram, Saeed, Cuiping Li, Rashid Mehmood, et al.. (2018). An ex vivo abomasal ovine model to study the immediate immune response in the context of Haemonchus contortus larval-stage. Veterinary Parasitology. 254. 105–113. 7 indexed citations
8.
Ding, Yili, et al.. (2017). Efficient and practical synthesis of Fondaparinux. Bioorganic & Medicinal Chemistry Letters. 27(11). 2424–2427. 22 indexed citations
9.
Yan, Shunqi, Gary Larson, Jim Zhen Wu, et al.. (2006). Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorganic & Medicinal Chemistry Letters. 17(1). 63–67. 46 indexed citations
10.
Ding, Yili, Jean‐Luc Girardet, Kenneth L. Smith, et al.. (2005). Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase. Bioorganic Chemistry. 34(1). 26–38. 49 indexed citations
11.
Ding, Yili, Jean‐Luc Girardet, Kenneth L. Smith, et al.. (2004). Parallel synthesis of pteridine derivatives as potent inhibitors for hepatitis C virus NS5B RNA-dependent RNA polymerase. Bioorganic & Medicinal Chemistry Letters. 15(3). 675–678. 28 indexed citations
12.
Ding, Yili, Jean‐Luc Girardet, Zhi Hong, et al.. (2004). Synthesis of 9-(2-β-C-methyl-β-d-ribofuranosyl)-6-substituted purine derivatives as inhibitors of HCV RNA replication. Bioorganic & Medicinal Chemistry Letters. 15(3). 709–713. 24 indexed citations
13.
Ding, Yili, Steven A. Hofstadler, Eric E. Swayze, Lisa M. Risen, & Richard H. Griffey. (2003). Design and Synthesis of Paromomycin‐Related Heterocycle‐Substituted Aminoglycoside Mimetics Based on a Mass Spectrometry RNA‐Binding Assay. Angewandte Chemie International Edition. 42(29). 3409–3412. 31 indexed citations
14.
Miura, Yoshiaki, et al.. (1999). Characterization of mammalian UDP-GalNAc:glucuronide  1-4-N-acetylgalactosaminyltransferase. Glycobiology. 9(10). 1053–1060. 6 indexed citations
15.
Ding, Yili, Ole Hindsgaul, Hong Li, & Monica M. Palcic. (1998). βGal(1→S-4)βGlcNAc-OR: A galactosidase-stable substrate for α(1→3)fucosyltransferase. Bioorganic & Medicinal Chemistry Letters. 8(22). 3199–3202. 5 indexed citations
16.
Ding, Yili, et al.. (1998). Efficient synthesis of 3′-glycosylated LacNAc-based oligosaccharides. Bioorganic & Medicinal Chemistry Letters. 8(14). 1903–1908. 12 indexed citations
17.
Ong, Edgar, Jiunn‐Chern Yeh, Yili Ding, Ole Hindsgaul, & Minoru Fukuda. (1998). Expression Cloning of a Human Sulfotransferase That Directs the Synthesis of the HNK-1 Glycan on the Neural Cell Adhesion Molecule and Glycolipids. Journal of Biological Chemistry. 273(9). 5190–5195. 80 indexed citations
18.
Ding, Yili, et al.. (1996). Towards oligosaccharide libraries: A study of the random galactosylation of unprotected N-acetylglucosamine. Bioorganic & Medicinal Chemistry. 4(5). 683–692. 35 indexed citations
19.
Contour-Galcéra, Marie-Odile, Yili Ding, Carmen Ortiz Mellet, & Jacques Defaye. (1996). Stereocontrolled synthesis of sulfur-linked analogues of the branched tetrasaccharide repeating-unit of the immunostimulant polysaccharide schizophyllan and of its β-(1 → 3)-branched, β-(1 → 6)-linked isomer. Carbohydrate Research. 281(1). 119–128. 10 indexed citations
20.
Kanie, Osamu, Frank Barresi, Yili Ding, et al.. (1996). A Strategy of “Random Glycosylation” for the Production of Oligosaccharide Libraries. Angewandte Chemie International Edition in English. 34(23-24). 2720–2722. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen A. Margosiak Breakdown of academic impact, for papers by Özlem Doǧan Ekici Breakdown of academic impact, for papers by Juliana L. Asgian Breakdown of academic impact, for papers by Christine Jaxel Breakdown of academic impact, for papers by Tomowo Kobayashi Breakdown of academic impact, for papers by S.M. Soisson Breakdown of academic impact, for papers by Anthony J. Cocuzza Breakdown of academic impact, for papers by Gary T. Wang Breakdown of academic impact, for papers by Zhimeng Wu Breakdown of academic impact, for papers by Martin Haraldsson
Rankless by CCL
2026